| William F Darby Jr, MD | |
|
665 West Alexander Road, Greenwood, SC 29646 | |
| (864) 227-2020 | |
| (864) 227-2823 |
| Full Name | William F Darby Jr |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 665 West Alexander Road, Greenwood, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720085087 | NPI | - | NPPES |
| 167731 | Medicaid | SC | |
| CE6166 | Other | SC | RAILROAD MEDICARE GROUP |
| 180028320 | Other | SC | RAILROAD MEDICARE |
| PA0515 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 16773 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William F Darby Jr, MD Po Box 369, Greenwood, SC 29648-0369 Ph: (864) 227-2020 | William F Darby Jr, MD 665 West Alexander Road, Greenwood, SC 29646 Ph: (864) 227-2020 |
News Archive
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Molecular Health announced today it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor". This latest patent supports Molecular Health's discovery that EPHB4 is a novel receptor for Erythropoietin (EPO), where EPHB4 binds to EPO and promotes tumor growth.
An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators from Dana-Farber Cancer Institute and M.D. Anderson Cancer Center.
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review the company's new drug application (NDA) for carfilzomib for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies. ODAC will review carfilzomib at its meeting on June 20, 2012.
People who get dizzy several minutes after standing up may be at risk of more serious conditions and even an increased risk of death, according to new research published in the September 23, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 2 days ago
Jennifer Lynn Hershberger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 665 West Alexander Road, Greenwood, SC 29646 Phone: 864-227-2020 | |
Jerry E Galloway, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 202 Overland Dr, Greenwood, SC 29646 Phone: 864-943-2010 Fax: 864-323-0345 | |
Timothy L. Austin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 665 West Alexander Road, Greenwood, SC 29646 Phone: 864-227-2020 Fax: 864-227-2823 | |
John Devore Compton Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 210 Wells Ave, Greenwood, SC 29646 Phone: 864-227-2020 Fax: 864-227-2823 | |
Stephanie C. Turner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 665 West Alexander Road, Greenwood, SC 29646 Phone: 864-227-2020 Fax: 864-227-2823 | |
Marvin G. Burdette Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 665 West Alexander Road, Greenwood, SC 29646 Phone: 864-227-2020 Fax: 864-227-2823 |